These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15989436)

  • 1. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project.
    Molitor F; Kuenneth C; Waltermeyer J; Mendoza M; Aguirre A; Brockmann K; Crump C
    AIDS Patient Care STDS; 2005 Jun; 19(6):406-12. PubMed ID: 15989436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.
    Fuller CM; Galea S; Caceres W; Blaney S; Sisco S; Vlahov D
    Am J Public Health; 2007 Jan; 97(1):117-24. PubMed ID: 17138929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of hospitalization for HIV-positive women and men drug users, 1996-2000.
    Schoenbaum EE; Lo Y; Floris-Moore M
    Public Health Rep; 2002; 117 Suppl 1(Suppl 1):S60-6. PubMed ID: 12435828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of longer time from HIV result to enrollment in publicly funded care and treatment in California by race/ethnicity and behavioral risk.
    Molitor F; Walsh RM; Leigh JP
    AIDS Patient Care STDS; 2002 Nov; 16(11):555-65. PubMed ID: 12513904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
    Kahn JG; Zhang X; Cross LT; Palacio H; Birkhead GS; Morin SF
    Public Health Rep; 2002; 117(3):252-62; discussion 231-2. PubMed ID: 12432136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.
    Chakrapani V; Velayudham J; Shunmugam M; Newman PA; Dubrow R
    AIDS Care; 2014; 26(7):835-41. PubMed ID: 24283220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2013 HIV Continuum of Care in Tennessee: Progress Made, but Disparities Persist.
    Wester C; Rebeiro PF; Shavor TJ; Shepherd BE; McGoy SL; Daley B; Morrison M; Vermund SH; Pettit AC
    Public Health Rep; 2016 Sep; 131(5):695-703. PubMed ID: 28123210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locating and linking to medical care HIV-positive persons without a history of care: findings from the California Bridge Project.
    Molitor F; Waltermeyer J; Mendoza M; Kuenneth C; Aguirre A; Brockmann K; Crump C
    AIDS Care; 2006 Jul; 18(5):456-9. PubMed ID: 16777637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and Facilitators for Antiretroviral Treatment Adherence Among HIV-Positive African American and Latino Men Who Have Sex With Men.
    Carey JW; Carnes N; Schoua-Glusberg A; Kenward K; Gelaude D; Denson DJ; Gall E; Randall LA; Frew PM
    AIDS Educ Prev; 2019 Aug; 31(4):306-324. PubMed ID: 31361514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use and HIV risk in a sample of severely mentally Ill Puerto Rican women.
    Loue S; Sajatovic M; Mendez N
    J Immigr Minor Health; 2011 Aug; 13(4):681-9. PubMed ID: 21327967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patients from a Veteran's Administration Hospital in northern California.
    Kemppainen JK; Levine RE; Mistal M; Schmidgall D
    AIDS Patient Care STDS; 2001 Mar; 15(3):117-27. PubMed ID: 11313024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
    Carrieri MP; Moatti JP; Vlahov D; Obadia Y; Reynaud-Maurupt C; Chesney M
    J Epidemiol Community Health; 1999 Jan; 53(1):4-8. PubMed ID: 10326045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.
    Altice FL; Springer S; Buitrago M; Hunt DP; Friedland GH
    J Urban Health; 2003 Sep; 80(3):416-27. PubMed ID: 12930880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Church-Based HIV Screening in Racial/Ethnic Minority Communities of California, 2011-2012.
    Williams MV; Derose KP; Aunon F; Kanouse DE; Bogart LM; Griffin BA; Haas AC; Collins DO
    Public Health Rep; 2016 Sep; 131(5):676-684. PubMed ID: 28123208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: accessible primary health care--a foundation to improve health outcomes for people who inject drugs.
    van Beek I
    Int J Drug Policy; 2007 Aug; 18(4):329-32. PubMed ID: 17689383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary syringe exchange among injection drug users.
    Snead J; Downing M; Lorvick J; Garcia B; Thawley R; Kegeles S; Edlin BR
    J Urban Health; 2003 Jun; 80(2):330-48. PubMed ID: 12791808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.